OJ-038 Comparison of 4 Years Efficacy and Durability of SES and PES Deployment in Patients with Very Long Coronary Lesions(OJ07,Coronary Revascularization, PCI (Complex Lesions) 1 (IHD),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of Th
スポンサーリンク
概要
- 論文の詳細を見る
- 2009-03-01
著者
-
Nakamura Sunao
Department of Cardiology, New Tokyo Hospital
-
Ogawa Hisao
Kumamoto University Hospital
-
Jang-Ho Bae
Konyang University Hospital
-
Wasan Udayachalerm
King Chulalongkorn Memorial Hospital
-
Damras Tresukosol
Her Majesty's Cardiac Center, Siriraj Hospital
-
Sudaratana Tansuphaswadikul
Chest Disease Institute
-
Hans Cahyadi
Husada Hospital
-
Ogawa Hisao
Department of Cardiology, Kumamoto University
-
Bae Jang-Ho
Konyang University Hospital
-
Hans Yeo
Husada Hospital
-
Ogawa Hisao
Kumamoto University
-
Ogawa Hisao
Department Of Cardiology Kumamoto University
-
Nakamura Shotaro
Secomedic Hospital
-
Cahyadi Yeo
Husada Hospital
-
Udayachalerm Wasan
King Chulalongkorn Memorial Hospital
-
Tansuphaswadikul Sudaratana
Chest Disease Institute
-
Nakamura Sunao
Department Of Cardiology New Tokyo Hospital
-
Cahyadi Yeohans
Husada Hospital
-
Tresukosol Damras
Her Majesty's Cardiac Center Siriraj Hospital
-
Cahyadi Yeo
Department Of Cardiology Husada Hospital
-
Damras Tresukosol
Her Majesty's Cardiac Center Siriraj Hospital
関連論文
- Radiofrequency Energy Induced Ventricular Fibrillation in a Case of Idiopathic Premature Ventricular Contraction Originating from the Left Ventricular Papillary Muscle
- Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study : a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combin
- PE-533 The Combination of Selective Aldosterone Blocker and CCB Exerts Additive Protective Effects against Salt-sensitive Hypertension-induced Cardiovascular Injury(PE089,Cardiomyopathy/Hypertrophy (Basic) (M),Poster Session (English),The 73rd Annual Scie
- PJ-123 Rotational Atherectomy Prior to the Stenting with Sirolimus-Eluting Stent for Diffuse In-Stent Restenosis : Multicenter Registry in Asia(PJ021,Coronary Revascularization, PCI (Complex Lesions) (IHD),Poster Session (Japanese),The 73rd Annual Scienti
- PJ-122 Drug-Eluting Stents for the Treatment of CTO : A Comparison with Sirolimus, Paclitaxel, Zotarolimus, EPC Capture and Everolimus-Eluting Stent: Multicenter Registry(PJ021,Coronary Revascularization, PCI (Complex Lesions) (IHD),Poster Session (Japane
- OJ-125 Rotational Atherectomy Prior to the Stenting with Sirolimus-Eluting Stent for Long Coronary Lesions : Multicenter Registry in Asia(OJ21,Coronary Revascularization, PCI (Complex Lesions) 2 (IHD),Oral Presentation (Japanese),The 73rd Annual Scientifi
- OJ-124 Comparison of 4Years Efficacy and Durability of DES Implantation in Non-bifurcation and Bifurcation Lesion of Unprotected LMT : Multicenter Registry(OJ21,Coronary Revascularization, PCI (Complex Lesions) 2 (IHD),Oral Presentation (Japanese),The 73r
- OJ-123 Systematic Double Stenting versus Simple Provisional T-stenting for True Bifurcation Lesions of LMT Disease Using Drug Eluting Stents : Multicenter Registry(OJ21,Coronary Revascularization, PCI (Complex Lesions) 2 (IHD),Oral Presentation (Japanese)
- OJ-122 Impact of Sirolimus-Eluting Stent and Paclitaxel-Eluting Stent on the Outcome of Patients with Sirolimus-Eluting Stent Failure : Multicenter Registry in Asia(OJ21,Coronary Revascularization, PCI (Complex Lesions) 2 (IHD),Oral Presentation (Japanese
- OJ-039 Drug-Eluting Stents for the Treatment of Left Main Coronary Artery Disease with Sirolimus, Paclitaxel, Zotarolimus, EPC Capture and Everolimus-Eluting Stent(OJ07,Coronary Revascularization, PCI (Complex Lesions) 1 (IHD),Oral Presentation (Japanese)
- OJ-038 Comparison of 4 Years Efficacy and Durability of SES and PES Deployment in Patients with Very Long Coronary Lesions(OJ07,Coronary Revascularization, PCI (Complex Lesions) 1 (IHD),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of Th
- 1 Low Incidence of Stent Thrombosis in Asian Races : Multicenter Registry in Asia 3 Years Follow-Up Result(Current Status and Future Perspective of Drug-Eluting Stents,Plenary Session 1 (PL-1) (A),The 73rd Annual Scientific Meeting of The Japanese Circula
- PJ-005 Localization of von Willebrand Factor-cleaving Protease (ADAMTS-13) in Coronary Thrombi from Patients with Acute Myocardial Infarction(Acute myocardial infarction, clinical (pathophysiology)-3 (IHD) PJ1,Poster Session (Japanese),The 70th Anniversar
- The Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension
- PJ-005 Localization of von Willebrand Factor-cleaving Protease (ADAMTS-13) in Coronary Thrombi from Patients with Acute Myocardial Infarction(Acute myocardial infarction, clinical (pathophysiology)-3 (IHD) PJ1,Poster Session (Japanese),The 70th Anniversar
- PJ-123 Rotational Atherectomy Prior to the Stenting with Sirolimus-Eluting Stent for Diffuse In-Stent Restenosis : Multicenter Registry in Asia(PJ021,Coronary Revascularization, PCI (Complex Lesions) (IHD),Poster Session (Japanese),The 73rd Annual Scienti
- PJ-122 Drug-Eluting Stents for the Treatment of CTO : A Comparison with Sirolimus, Paclitaxel, Zotarolimus, EPC Capture and Everolimus-Eluting Stent: Multicenter Registry(PJ021,Coronary Revascularization, PCI (Complex Lesions) (IHD),Poster Session (Japane
- OJ-125 Rotational Atherectomy Prior to the Stenting with Sirolimus-Eluting Stent for Long Coronary Lesions : Multicenter Registry in Asia(OJ21,Coronary Revascularization, PCI (Complex Lesions) 2 (IHD),Oral Presentation (Japanese),The 73rd Annual Scientifi
- OJ-124 Comparison of 4Years Efficacy and Durability of DES Implantation in Non-bifurcation and Bifurcation Lesion of Unprotected LMT : Multicenter Registry(OJ21,Coronary Revascularization, PCI (Complex Lesions) 2 (IHD),Oral Presentation (Japanese),The 73r
- OJ-123 Systematic Double Stenting versus Simple Provisional T-stenting for True Bifurcation Lesions of LMT Disease Using Drug Eluting Stents : Multicenter Registry(OJ21,Coronary Revascularization, PCI (Complex Lesions) 2 (IHD),Oral Presentation (Japanese)
- OJ-122 Impact of Sirolimus-Eluting Stent and Paclitaxel-Eluting Stent on the Outcome of Patients with Sirolimus-Eluting Stent Failure : Multicenter Registry in Asia(OJ21,Coronary Revascularization, PCI (Complex Lesions) 2 (IHD),Oral Presentation (Japanese
- OJ-039 Drug-Eluting Stents for the Treatment of Left Main Coronary Artery Disease with Sirolimus, Paclitaxel, Zotarolimus, EPC Capture and Everolimus-Eluting Stent(OJ07,Coronary Revascularization, PCI (Complex Lesions) 1 (IHD),Oral Presentation (Japanese)
- OJ-038 Comparison of 4 Years Efficacy and Durability of SES and PES Deployment in Patients with Very Long Coronary Lesions(OJ07,Coronary Revascularization, PCI (Complex Lesions) 1 (IHD),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of Th
- 1 Low Incidence of Stent Thrombosis in Asian Races : Multicenter Registry in Asia 3 Years Follow-Up Result(Current Status and Future Perspective of Drug-Eluting Stents,Plenary Session 1 (PL-1) (A),The 73rd Annual Scientific Meeting of The Japanese Circula
- PE-037 A Q312X Mutation in the Hemojuvelin Gene is Associated with Cardiomyopathy due to Juvenile Hemochromatosis(Cardiomyopathy, basic/clinical(03)(M),Poster Session(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- OE-323 Functional Assay of von Willebrand Factor (VWF) and VWF-cleaving Protease (ADAMTS13) Activity in Acute Myocardial Infarction(Acute myocardial infarction, clinical(pathophysiology)(01)(IHD),Oral Presentation(English),The 72nd Annual Scientific Meeti
- PJ-704 Delays of Hospital Admission from the Onset of Acute Myocardial infarction Induce Poor Prognosis in Women in Kumamoto Prefecture(Preventive medicine/Epidemiology/Education-5, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-188 Changes in Plasma Von Willebrand Factor-cleaving Protease (ADAMTS13) Levels in Patients with Unstable Angina(Angina pectoris, basic/clinical-4, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PE-179 Changes in Von Willebrand Factor-cleaving Protease (ADAMTS13) and Prognosis after Acute Myocardial Infarction(Thromboembolism/Antithrombotic therapy/Thrombolysis-3, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- OE-052 Targeted Deletion of Class A Macrophage Scavenger Receptor (CD204) Increases the Risk of Cardiac Rupture after Experimental Myocardial Infarction(Acute myocardial infarction, basic-1, The 71st Annual Scientific Meeting of the Japanese Circulation S
- FRS-004 The Effect of Edaravone on Plasma Monocyte Chemoattractant Protein-1 Levels in Patients with Acute Myocardial Infarction(Acute Coronary Syndrome, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PE-125 Long-term Clinical Outcome after Use of a Distal Protection Device in Patients with Acute Myocardial Infarction(Acute myocardial infarction, clinical (diagnosis/treatment)-6 (IHD) PE21,Poster Session (English),The 70th Anniversary Annual Scientific
- Captopril Reduced Plasminogen Activater Inhibiter Activity in Patients With Acute Myocardial Infarction
- PJ-727 Percutaneous Coronary Intervention for Acute Myocardial Infarction in the Elderly : Comparison on Clinical Outcome between Younger Patients, Septuagenarians and Octogenarians(Coronary revascularization, PCI-17, The 71st Annual Scientific Meeting of
- OJ-102 Coronary Artery Perforations : Incidence, Predictors and Clinical Outcomes : Multicenter Registry in Japan(Coronary revascularization, PCI-06, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- FRS-082 Features and Preliminary Results of the Multicenter Registry of the Coronary Spasm Association(FRS17,Novel Approaches to Treatment of CAD (IHD),Featured Research Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Soci
- PJ-466 Successful Embolization Protection Using GuardWire System for Acute Myocardial Infarction : Multicenter GuardWire Registry in Japan(Coronary Circulation, Basic/Clinical 4 (IHD) : PJ78)(Poster Session (Japanese))
- OJ-472 Impact of Devices and Technique Improvement on the Clinical Outcome of Percutaneous Coronary Intervention for Chronic Total Occlusions(Angina Pectoris, Clinical 3 (IHD) : OJ58)(Oral Presentation (Japanese))
- OJ-353 Treatment of Totally Occlusive Diffuse In-Stent Restenosis : Multicenter Registry in Japan(Coronary Revascularization, PTCA/Stent/DCA/Rotablator/New Device 9 (IHD) : OJ43)(Oral Presentation (Japanese))
- OJ-352 Systematic Complex Stenting Versus Simple Provisional T-stenting for True Bifurcation Lesions(Coronary Revascularization, PTCA/Stent/DCA/Rotablator/New Device 9 (IHD) : OJ43)(Oral Presentation (Japanese))
- OJ-180 Cutting Balloon Angioplasty Versus Stenting for Superficial Femoral Artery : Multicenter Registry in Japan(Peripheral Circulation/Vascular Disease 1 (H) : OJ21)(Oral Presentation (Japanese))
- FRS-127 Influence of Diabetes Mellitus in Patients with Long Coronary Lesions Undergoing Percutaneous Coronary Interventions : Multicenter Registry in Japan(Metabolic Syndrome (H) : FRS15)(Featured Research Session (English))
- Percutaneous coronary intervention in octogenarian population : comparison with elderly patients
- Is Stenting without Predilatation Feasible? Multi Center Experience
- Cutting Balloon Angioplasty Versus Rotational Atherectomy for Treatment of Diffuse In-stent Restenosis
- Treatment of Long Coronary Lesions with Stenting and Rotational Atherectomy
- Comparison of Efficacy Between Sirolimus-Eluting Stent (Cypher^) and Paclitaxel-Eluting Stent (TAXUS^) in Unprotected Left Main Coronary Arteries (Angina Pectoris, Basic/Clinical 4 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulat
- One-Year Clinical Outcome of Cypher Sirolimus-Eluting Stents in Patients with Long Coronary Lesions : Multicenter Registry in Asia (Coronary Revascularization, PTCA/Stent/DCA/Rotablator/New Device 8 (IHD), The 69th Annual Scientific Meeting of the Japanes
- Comparison of Efficacy Between Sirolimus-Eluting Stent and Paclitaxel-Eluting Stent on the Outcome of Patients with Chronic Total Occlusions (Coronary Revascularization, PTCA/Stent/DCA/Rotablator/New Device 8 (IHD), The 69th Annual Scientific Meeting of t
- Durable Clinical Benefit Following Sirolimus-Eluting Stent Deployment on the Outcome of Patients with Unprotected Left Main Coronary Arteries 2-Year Results(Coronary Revascularization, PTCA/Stent/DCA/Rotablator/New Device 17 (IHD), The 69th Annual Scienti
- Impact of Sirolimus-Eluting Stents on the One-Year Outcome of Patients with Bifurcation Lesions : Multicenter Registry in Asia(Coronary Revascularization, PTCA/Stent/DCA/Rotablator/New Device 17 (IHD), The 69th Annual Scientific Meeting of the Japanese Ci
- Durable Clinical Benefit Following Sirolimus-Eluting Stent Deployment on the Outcome of Patients with Diffuse In-Stent Restenosis : Multicenter Registry in Asia(Angina Pectoris, Basic/Clinical 5 (IHD), The 69th Annual Scientific Meeting of the Japanese Ci
- Durable Clinical Benefit Following Sirolimus-Eluting Stent (Cypher^) Deployment on the Outcome of Patients with Chronic Total Occlusions 2-Year Results(Coronary Revascularization, PTCA/Stent/DCA/Rotablator/New Device 9 (IHD), The 69th Annual Scientifi
- Comparison of Efficacy between Sirolimus-Eluting Stent and Paclitaxel-Eluting Stent on the Outcome of Patients with Diffuse In-Stent Restenosis(Coronary Revascularization, PTCA/Stent/DCA/Rotablator/New Device 3 (IHD), The 69th Annual Scientific Meeting of
- OJ-110 Initial Clinical Experience of Cypher Stents in Unprotected Left Main Coronary Arteries(Coronary Revascularization, PICA/Stent/DCA/Rotablator/New Device 2 (IHD) : OJ14)(Oral Presentation (Japanese))
- FRS-182 Impact of Sirolimus-Eluting Stents on the Outcome of Patients with Chronic Total Occlusions : Multicenter Registry in Asia(Percutaneous Coronary Intervention (IHD) : FRS21)(Featured Research Session (English))
- PE-005 Gene Expression Profile of Circulating Mononuclear Cells in Patients with Acute Coronary Syndrome(Acute coronary syndrome, basic/clinical-4 (IHD) PE1,Poster Session (English),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulatio
- 4 Comparison of Efficacy and Durability between Sirolimus-Eluting Stent and Paclitaxel-Eluting Stent in Unprotected Left Main Coronary Arteries(Plenary Session 1 (PL-1) (IHD) Drug-Eluting Stents : Long-Term Effects and Emerging Problems,Special Program,Th
- PJ-771 Diabetic Patients Requiring Insulin Therapy Have Worse Clinical Outcome after Drug-Eluting Stent Implantation : Multicenter Registry in Asia(Diabetes/Obesity/Metabolic syndrome-11, The 71st Annual Scientific Meeting of the Japanese Circulation Soci
- PJ-753 Rotational Atherectomy Prior to the Stenting with Sirolimus-Eluting Stent for Diffuse In-Stent Restenosis : Multicenter Registry in Asia(Coronary revascularization, PCI-22, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-732 Rotational Atherectomy Prior to the Stenting with Sirolimus-Eluting Stent for Long Coronary Lesions : Multicenter Registry in Asia(Coronary revascularization, PCI-18, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-728 Drug-Eluting Stents for the Treatment of Chronic Total Occlusion : A Comparison with Sirolimus, Paclitaxel, Zotarolimus and Tacrolimus-Eluting Stent(Coronary revascularization, PCI-18, The 71st Annual Scientific Meeting of the Japanese Circulation
- PJ-603 Impact of Sirolimus-Eluting Stent and Paclitaxel-Eluting Stent on the Outcome of Patients with Sirolimus-Eluting Stent Failure : Multicenter Registry in Asia(Coronary revascularization, PCI-16, The 71st Annual Scientific Meeting of the Japanese Cir
- PJ-602 Comparison of Efficacy and Safety between Sirolimus-Eluting Stent and Paclitaxel-Eluting Stent in Patients with Diffuse In-Stent Restenosis(Coronary revascularization, PCI-16, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-596 Drug-Eluting Stents for the Treatment of Very Long Coronary Artery Stenosis : A Comparison with Sirolimus, Paclitaxel, Zotarolimus and Tacrolimus-Eluting Stent(Coronary revascularization, PCI-15, The 71st Annual Scientific Meeting of the Japanese C
- PJ-595 Drug-Eluting Stent for the Treatment of Small Coronary Artery with Sirolimus, Paclitaxel, Zotarolimus and Tacrolimus-Eluting Stent(Coronary revascularization, PCI-15, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-594 Drug-Eluting Stents for the Treatment of Left Main Coronary Arteries with Sirolimus, Paclitaxel, Zotarolimus and Tacrolimus-Eluting Stent(Coronary revascularization, PCI-14, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-590 Impact of Sirolimus-Eluting Stents on the One-Year Outcome of Patients with Bifurcation Lesions : Multicenter Registry in Asia(Coronary revascularization, PCI-14, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- FRS-008 Durable Clinical Benefit Following Sirolimus-Eluting Stent Deployment in Patients with Unprotected Left Main Arteries : Multicenter Registry in Asia 4-Year Results(Coronary Revascularization (clinical) 1, The 71st Annual Scientific Meeting of the
- 2 Drug-Eluting Stents for the Treatment of Left Main Coronary Artery Disease with Sirolimus, Paclitaxel, Zotarolimus and Tacrolimus-Eluting Stent(Strategies for Treatment of Left Main Trunk Disease, The 71st Annual Scientific Meeting of the Japanese Circu
- Systematic Complex Stenting Versus Simple Provisional T-stenting for True Bifurcation Lesions Using Bare Metal Stents : Multicenter Registry in Japan (Coronary Revascularization, PTCA/Stent/DCA/Rotablator/New Device 15 (IHD), The 69th Annual Scientific Me
- Treatment of False Bifurcation Lesions with Provisional Coronary T-stenting Using Bare Metal Stents : Multicenter Registry in Japan (Coronary Revascularization, PTCA/Stent/DCA/Rotablator/New Device 12 (IHD), The 69th Annual Scientific Meeting of the Japan
- Cutting Balloon Angioplasty Versus Stenting for Superficial Femoral Artery : Multicenter Registry in Japan(Peripheral Circulation/Vascular Disease 1 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Influence of Diabetes Mellitus in Patients with Long Coronary Lesions Undergoing Percutaneous Coronary Interventions : Multicenter Registry in Japan(Diabetes/Obesity 9 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Impact of Diabetes Mellitus in Patients with Diffuse In-Stent Restenosis Undergoing Percutaneous Coronary Intervention : Multicenter Registry in Japan(Diabetes/Obesity 8 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Endoluminal Stenting for Obstructive Lesions of the Subclavian Artery : Multicenter Registry in Japan(Peripheral Circulation/Vascular Disease 3 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- FRS-119 The Effect of Drug-Eluting Stents on Clinical and Angiographic Outcomes in Diabetic Patients : Multicenter Registry in Asia(Coronary Revascularization (clinical) 2, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-420 Durable Clinical Benefit Following Paclitaxel-eluting Stent Deployment on the Outcome of Patients with Diffuse In-stent Restenosis : Multicenter Registry 2-year Results(Restenosis, basic/clinical-5 (IHD) PJ71,Poster Session (Japanese),The 70th Anni
- OJ-158 Rotational Atherectomy Prior to the Stenting with Sirolimus-Eluting Stent for Long Coronary Lesions : Multicenter Registry in Asia(Chronic coronary heart disease/Remodeling-2 (IHD) OJ27,Oral Presentation (Japanese),The 70th Anniversary Annual Scien
- PJ-010 Three-Year Follow-Up Patients with ST Segment Elevation Acute Myocardial Infarction Treated with Sirolimus-Eluting Stent and Paclitaxel-Eluting Stent : Multicenter Registry in Asia(Acute myocardial infarction, clinical (diagnosis/treatment)-5, The
- PJ-419 Durable Clinical Benefit Following Sirolimus-eluting Stent Deployment on the Outcome of Patients with Diffuse In-stent Restenosis : Multicenter Registry 3-year Results(Restenosis, basic/clinical-5 (IHD) PJ71,Poster Session (Japanese),The 70th Anniv
- PJ-354 Durable Clinical Benefit Following Sirolimus-eiuting Stent on the Outcome of Patients with Unprotected Left Main Coronary Arteries : Multicenter-registry 3-year Results(Coronary revascularization, PCI-15 (IHD) PJ60,Poster Session (Japanese),The 70t
- OJ-234 Rotational Atherectomy Prior to the Stenting with Sirolimus-Eluting Stent for Diffuse In-Stent Restenosis : Multicenter Registry in Asia(Restenosis, basic/clinical-2 (IHD) OJ39,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Mee
- OJ-233 Comparison of Efficacy and Safety between Sirolimus-Eluting Stent and Paclitaxel-Eluting Stent on the Outcome of Patients with Diffuse In-Stent Restenosis(Restenosis, basic/clinical-2 (IHD) OJ39,Oral Presentation (Japanese),The 70th Anniversary Ann
- OJ-161 Durable Clinical Benefit Following Sirolimus-Eluting Stent Deployment on the Outcome of Patients with Chronic Total Occlusions : Multicenter Registry 3-Year Results(Chronic coronary heart disease/Remodeling-2 (IHD) OJ27,Oral Presentation (Japanese)
- OJ-098 Durable Clinical Benefit Following Paclitaxel-Eluting Stent on the Outcome of Patients with Very Long Coronary Lesions : Multicenter Registry 2-Year Results(Coronary revascularization, PCI-5 (IHD) OJ17,Oral Presentation (Japanese),The 70th Annivers
- FRS-006 Long-Term Follow-Up Patients with ST-Segment Elevation Acute Myocardial Infarction Treated with Sirolimus-Eluting Stent and Paclitaxel-Eluting Stent(Strategies to Acute Myocardial Infarction-2 (IHD) FRS2,Featured Research Session,The 70th Annivers
- 4 Durable Clinical Benefit Following Several Sirolimus-Eluting Stenting on the Outcome of Patients with Unprotected Left Main Coronary Arteries(New Strategy of Coronary Intervention in DES Era,Plenary Session 1 (PL1) (IHD),The 70th Anniversary Annual Scie
- Population-Based Mortality of Acute Myocardial Infarction in the Japanese Survey of Myocardial Infarction in Nationwide Registration (JASMIN)
- Treatment of myocardial infarction in Japan for the investigators in the Japanese Survey of Myocardial Infarction in Nationwide registration (JASMIN)
- FRS-083 Durable Clinical Benefit Following Sirolimus-eluting Stent on the Outcome of Patients with Very Long Coronary Lesions : Multicenter Registry 2-year Results(New PCI-2 (IHD) FRS17,Featured Research Session (English),The 70th Anniversary Annual Scien
- FRS-081 Impact of Sirolimus-eluting Stents on the One-year Outcome of Patients with Bifurcation Lesions : Multicenter Registry in Asia(New PCI-2 (IHD) FRS17,Featured Research Session (English),The 70th Anniversary Annual Scientific Meeting of the Japanese
- PJ-512 Comparison of Efficacy between Sirolimus-eluting Stent and Paclitaxel-eluting Stent on the Outcome of Patients with Chronic Total Occlusions(Chronic coronary heart disease/Remodeling-4 (IHD) PJ86,Poster Session (Japanese),The 70th Anniversary Annua
- OJ-030 Impact of Sirolimus-Eluting Stents on the Outcome of Patients with Diffuse In-Stent Restenosis : Multicenter Registry in Asia(Restenosis, basic/clinical-1 (IHD) OJ5,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting of the
- OJ-009 Impact of Paclitaxel-Eluting Stents on the One-year Outcome of Patients with Bifurcation Lesions : Multicenter Registry in Asia(Coronary revascularization, PCI-4 (IHD) OJ2,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting
- OJ-008 Comparison of Efficacy and Safety between Sirolimus-Eluting Stent and Paclitaxel-Eluting Stent in Unprotected Left Main Coronary Arteries(Coronary revascularization, PCI-4 (IHD) OJ2,Oral Presentation (Japanese),The 70th Anniversary Annual Scientifi
- OJ-007 Durable Clinical Benefit Following Paclitaxel-Eluting Stent on the Outcome of Patients with Unprotected Left Main Coronary Arteries : Multicenter-Registry 2-year Results(Coronary revascularization, PCI-4 (IHD) OJ2,Oral Presentation (Japanese),The 7
- FRS-109 Comparison of Efficacy and Safety Between Sirolimus-eluting Stent and Paclitaxel-eluting Stent in Patients with Diabetes Mellitus : Multicenter-registry in Asia(Progress in Preventive Medicine-2 (H) FRS22,Featured Research Session (English),The 70
- PJ-508 Comparison of Efficacy and Safety between Sirolimus-eluting Stent and Paclitaxel-eluting Stent on the Outcome of Patients with Small Coronary Arteries(Chronic coronary heart disease/Remodeling-4 (IHD) PJ86,Poster Session (Japanese),The 70th Anniver